Abstract
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) is a new synthetic opioid and has led to multiple non-fatal and fatal intoxications. To comprehensively study AH-7921 metabolism, we assessed human liver microsome (HLM) metabolic stability, determined AH-7921's metabolic profile after human hepatocytes incubation, confirmed our findings in a urine case specimen, and compared results to in silico predictions. For metabolic stability, 1 µmol/L AH-7921 was incubated with HLM for up to 1 h; for metabolite profiling, 10 µmol/L was incubated with pooled human hepatocytes for up to 3 h. Hepatocyte samples were analyzed by liquid chromatography quadrupole/time-of-flight high-resolution mass spectrometry (MS). High-resolution full scan MS and information-dependent acquisition MS/MS data were analyzed with MetabolitePilot™ (SCIEX) using multiple data processing algorithms. The presence of AH-7921 and metabolites was confirmed in the urine case specimen. In silico prediction of metabolite structures was performed with MetaSite™ (Molecular Discovery). AH-7921 in vitro half-life was 13.5 ± 0.4 min. We identified 12 AH-7921 metabolites after hepatocyte incubation, predominantly generated by demethylation, less dominantly ...Continue Reading
References
Nov 1, 1974·Journal of Medicinal Chemistry·N J HarperD G Wibberley
Jul 1, 1983·British Journal of Pharmacology·A G Hayes, M B Tyers
Feb 1, 1997·Pharmaceutical Research·T LavéP Coassolo
Oct 12, 1999·Journal of Analytical Toxicology·M H SlawsonP L Bailey
Mar 14, 2008·Assay and Drug Development Technologies·Colleen A McNaneyMark Sanders
Mar 5, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kelsey L HansonKent L Kunze
Aug 16, 2011·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Kristof E MaudensWilly E Lambert
Sep 8, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Henriette Kold UldamLars Dalgaard
Aug 31, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Austin C LiIsmael Zamora
Feb 14, 2014·Journal of Analytical Toxicology·Shawn P VorceThomas Z Bosy
Feb 28, 2014·Drug Testing and Analysis·Yan Ni Annie Soh, Simon Elliott
Sep 14, 2014·Forensic Science International : Synergy·Ritva KarinenÅse Marit Leere Øiestad
Sep 14, 2014·Journal of Analytical Toxicology·R KronstrandF C Kugelberg
Citations
Jan 27, 2016·The AAPS Journal·Xingxing DiaoMarilyn A Huestis
May 28, 2016·Drug Testing and Analysis·Simon P ElliottChristopher Smith
Jul 3, 2016·Archives of Toxicology·H H Maurer, Markus R Meyer
Nov 20, 2016·Drug Testing and Analysis·Marcin RojkiewiczMieczysław Sajewicz
Apr 30, 2019·Expert Opinion on Drug Safety·Hong K KimMaryann E Mazer-Amirshahi
Aug 20, 2019·Drug Testing and Analysis·Tanja M GampferMarkus R Meyer
Oct 12, 2018·Clinical Chemistry·Paul J JannettoHemamalini Ketha
Sep 26, 2019·Scientific Reports·Frederike NordmeierMarkus R Meyer
Jul 6, 2018·Frontiers in Pharmacology·Renata SoliminiRaffaele Giorgetti
Apr 7, 2017·The AAPS Journal·Shimpei WatanabeAriane Wohlfarth
Oct 27, 2018·Frontiers in Pharmacology·Clara Pérez-MañáMagi Farré
Oct 7, 2017·Journal of Analytical Toxicology·Camilla MontesanoManuel Sergi
Jul 16, 2019·Forensic Sciences Research·Inês TabarraEugenia Gallardo
Nov 13, 2018·Frontiers in Pharmacology·Marta ConcheiroGail Cooper
Jan 1, 2021·International Journal of Molecular Sciences·Jeremy CarlierMarilyn A Huestis
Feb 14, 2021·Metabolites·Camilla MontesanoManuel Sergi
Sep 16, 2018·Neuroscience and Biobehavioral Reviews·Laurent KarilaAmine Benyamina
Apr 10, 2021·Drug Testing and Analysis·Sara OdoardiSabina Strano Rossi
Feb 27, 2018·ACS Omega·Natascha NebelOlaf Prante